investorscraft@gmail.com

Intrinsic ValueAMA Corporation Plc (ALAMA.PA)

Previous Close0.13
Intrinsic Value
Upside potential
Previous Close
0.13

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

AMA Corporation Plc operates in the healthcare information services sector, specializing in remote assistance solutions through its XpertEye platform. The company serves industrial organizations, service providers, and medical institutions globally, offering software that integrates with smartphones, tablets, smart glasses, and other connected devices. Its product suite, including XpertEye Lite, Essential, Advanced, Proceed, and Schedule, supports remote training, inspections, and real-time assistance, positioning it as a niche player in assisted reality technology. The company’s focus on industrial and medical applications differentiates it from broader SaaS providers, though its small scale limits direct competition with larger healthcare IT firms. Market adoption hinges on the growing demand for remote collaboration tools, particularly in sectors requiring specialized technical support. Headquartered in Rennes, France, AMA Corporation faces challenges in scaling its solutions against entrenched competitors but benefits from first-mover advantages in certain verticals.

Revenue Profitability And Efficiency

AMA Corporation reported revenue of €2.49 million for the period, reflecting its early-stage growth trajectory. However, net losses of €7.34 million and negative operating cash flow of €6.28 million highlight significant profitability challenges. Capital expenditures were minimal at €106,000, suggesting a lean operational model focused on software development rather than physical infrastructure. The company’s high beta of 3.095 indicates pronounced volatility, likely tied to its unproven financial performance and niche market focus.

Earnings Power And Capital Efficiency

Diluted EPS of -€0.199 underscores the company’s current lack of earnings power, with losses outweighing revenue generation. Negative operating cash flow further signals inefficiency in converting sales into sustainable liquidity. The absence of dividend payouts aligns with its reinvestment needs, though persistent losses raise questions about capital allocation effectiveness. The modest cash balance of €5.82 million relative to total debt of €4.03 million limits financial flexibility.

Balance Sheet And Financial Health

AMA Corporation’s balance sheet shows €5.82 million in cash against €4.03 million in total debt, yielding a net cash position but with limited runway given operating losses. The equity base is small, with a market cap of €10.65 million, reflecting investor skepticism. While not immediately distressed, the company’s reliance on future funding or operational turnaround to sustain operations is evident.

Growth Trends And Dividend Policy

Growth prospects hinge on broader adoption of remote assistance tools, though current revenue levels remain insufficient to offset costs. No dividends are paid, consistent with its reinvestment priorities. The company’s ability to scale its platform and reduce losses will be critical to attracting further investment or achieving breakeven. Market trends favor digital healthcare solutions, but execution risks persist.

Valuation And Market Expectations

The €10.65 million market cap suggests minimal investor confidence, likely due to sustained losses and high beta. Valuation multiples are inapplicable given negative earnings, leaving future pricing contingent on revenue acceleration or cost containment. The niche focus may appeal to specialized investors, but broader market appeal remains unproven without clearer profitability pathways.

Strategic Advantages And Outlook

AMA Corporation’s assisted reality platform addresses underserved industrial and medical use cases, offering differentiation in a crowded tech landscape. However, its small scale and financial constraints limit competitive moats. Success depends on securing strategic partnerships or achieving critical mass in key verticals. Near-term outlook remains uncertain, with liquidity and operational efficiency as decisive factors.

Sources

Company description and financial data sourced from publicly disclosed ticker information.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount